Everything below concerns freeze-thaw cycling. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-05-12. Where a claim depends on a specific study, the study is described rather than over-claimed.
Full-length thymosin beta-4 consists of roughly forty-three amino acids and ranks among the more abundant small proteins in the cytoplasm. The fragment is much shorter, so it cannot reproduce every function attributed to the intact molecule. In cell culture, short actin-binding motifs can interfere with filament dynamics and cell movement, but such observations come from controlled experiments rather than from whole-animal work. Whether a truncated fragment produces the same effects as the parent protein remains an open question.
Interest in the peptide grew during the 2000s and 2010s, when studies of tendon and ligament injuries in horses reported changes in lesion size after treatment. Those reports circulated widely outside the scientific literature and shaped much of the current online discussion. Subsequent reviews noted inconsistent study design, small groups, and a shortage of independent replication. Popular descriptions often blur the line between the fragment, the complete protein, and unrelated growth factors, which complicates comparisons across sources.
TB-500 is a synthetic peptide whose sequence corresponds to a short fragment near the N-terminus of thymosin beta-4, a small protein present in most mammalian cells. The fragment is commonly cited as containing the actin-binding region of the parent molecule, which is why it appears in laboratory work on cell migration and tissue repair. Suppliers distribute it as a lyophilised powder intended for research use. Its identity is defined by amino acid sequence and by the presence of an acetyl group on the N-terminal residue.
TB-500 is a research peptide whose sequence matches residues 17 to 23 of thymosin beta-4, a 43-residue protein present in most mammalian cells. The chain is seven amino acids long, written as LKKTETQ, and is normally supplied with an acetyl group on the N-terminus. Suppliers list it as a lyophilised powder under the code name TB-500, and the same sequence appears elsewhere in catalogues as the thymosin beta-4 actin-binding fragment. The label is commercial rather than systematic, so no single authority fixes exactly what TB-500 denotes.
Thymosin beta-4 was isolated from calf thymus in the early 1980s and later characterised as an abundant intracellular actin-sequestering protein. Interest in short synthetic fragments grew once the actin-binding motif had been mapped to the middle of the sequence. TB-500 came out of that line of work as a truncated analogue rather than a natural isolate, and it is now sold mainly to laboratories. Published studies on the fragment have been largely in vitro or in animal models, and controlled human trials remain sparse, so claims about effects in people rest on extrapolation.
Literature and online discussion often conflate TB-500 with full-length thymosin beta-4, even though the two differ in size and are not interchangeable in analytical terms. The fragment is produced by solid-phase peptide synthesis, and the product is a defined seven-residue chain rather than a biological extract. Because the term is a trade-style label, two vendors may supply materials of the same nominal sequence but different counter-ion content, purity, or water content. Comparisons across studies are therefore difficult unless the exact sequence and purity are reported.
| Property | Value | Notes |
|---|---|---|
| Generic designation | Synthetic thymosin beta-4 N-terminal fragment | Peptide nomenclature varies by supplier |
| Peptide length | Approximately 17 amino acid residues | Reported length sometimes differs between sources |
| N-terminal modification | Acetyl group | Affects mass and chromatographic behaviour |
| Compound class | Small synthetic peptide | Not a small-molecule drug |
| Common synonyms | TB4 fragment; thymosin beta-4 fragment | Naming is inconsistent in popular media |
TB-500 is a shorthand label used in supplier catalogs and online discussion for a short synthetic peptide described as a fragment of thymosin beta-4. Most product listings present it as the N-terminally acetylated heptapeptide Ac-LKKTETQ, a sequence corresponding to the actin-binding region of the parent protein. The name is not a formal chemical designation and does not appear in standard nomenclature systems. Because labeling practices vary between vendors, two products sold under the same name may not contain the same molecule, and the stated sequence should be treated as a claim rather than a fixed definition.
Thymosin beta-4 is a naturally occurring protein of 43 amino acids found in most mammalian cells, where it binds actin monomers and influences filament dynamics. It was first isolated from thymus tissue in the early 1980s, and its actin-binding activity was later mapped to a short region near the N-terminus. The synthetic fragment sold as TB-500 was designed to reproduce that region rather than the full protein. Whether a short fragment reproduces the behavior of the intact molecule remains an open question, since the parent protein carries additional structural elements outside the binding region.
Published research on the intact protein is substantial, covering actin regulation, cell migration, and wound models. Research using the heptapeptide fragment specifically is far smaller, and much of the circulating material originates in supplier documentation rather than peer-reviewed reports. Where fragment studies do exist, they often employ different sequences, chain lengths, or terminal modifications, which complicates direct comparison across papers. Readers encountering claims about TB-500 should therefore separate evidence about thymosin beta-4 from evidence about the fragment itself.
Identity and purity checks for peptide material typically combine reversed-phase high-performance liquid chromatography with mass measurement, since retention time alone cannot confirm a sequence. Mass measurement verifies the expected molecular mass within instrument tolerance, while chromatographic peak area provides a purity estimate. Anti-doping analysis of urine uses related but more sensitive workflows, sometimes after solid-phase extraction. For research material, batch documentation, certificate content, and independent testing are common points of scrutiny, because supply chains outside pharmaceutical regulation vary widely in the paperwork they provide.
Reconstitution of a lyophilized peptide is normally done with sterile water or a suitable buffer under aseptic conditions. Adding solvent down the vial wall and allowing gentle dissolution instead of vigorous vortexing reduces the chance of aggregation, which can lower the effective concentration of the resulting solution. Concentrated stocks are usually diluted into working buffer shortly before use. Because no standard preparation protocol exists for TB-500 specifically, laboratories adapt general peptide handling practice, and reported results may reflect differing preparation choices.
Dry peptide powder is commonly kept at −20 °C in a desiccated container away from light, a practice that limits moisture uptake and oxidation. Once dissolved, solutions are generally held at 2–8 °C for short periods or frozen at −20 °C or lower for longer storage, with repeated freeze-thaw cycles avoided. Hydrolysis and oxidation are the main degradation routes for peptides in solution, and both accelerate at higher temperature or extreme pH. Published stability data specific to TB-500 are limited, so shelf life should be treated as uncertain.
Purity and identity are separate measurements and are often confused. Reverse-phase high-performance liquid chromatography, usually with ultraviolet detection near 214 nanometres, reports the share of total peak area belonging to the target compound. Mass spectrometry by electrospray or matrix-assisted laser desorption then checks whether the observed mass matches the expected sequence. Neither measurement alone shows that a vial holds the intended peptide. Peptide content, meaning the fraction of vial mass that is genuine peptide rather than counter-ion, water or residual acid, is reported separately and is frequently lower than the stated purity figure.
The regulatory position is broadly consistent across major jurisdictions: no thymosin beta-4 fragment is an approved medicine, and laboratory material is commonly labelled as not intended for human consumption. Anti-doping rules in sport list thymosin beta-4 and its fragments among prohibited peptide hormones. Because these products travel through research-chemical channels rather than pharmaceutical supply chains, quality varies considerably between vendors. Independent testing of identity, purity and sterility is the only dependable check, and a certificate of analysis describes one batch rather than a supplier's whole catalogue.
According to the assessment of Andrey Illarionov, the actions of the peacekeeping battalion commanded by Timerman triggered the hot phase of armed hostilities. In 2017, Timerman said that he got transferred to the 135th Regiment of the 58th Army in Prokhladny, Kabardino-Balkarian Republic in 2007. He knew that the situation was tense in South Ossetia and "Armed hostilities were practiced at the training center at the Sernovodsk training ground." He arrived in South Ossetia on 31 May 2008.
Psychological Types—a framework for consciously orienting psychotherapists to patients by raising particular modes of personality to consciousness and differentiation between analyst and patient. Shadow—(archetype) the repressed, therefore unknown, aspects of the personality, including those often considered to be negative. Self—(archetype) the central overarching concept governing the individuation process, as symbolized by mandalas, the union of male and female, totality, and unity. Jung viewed it as the psyche's central archetype. Synchronicity—an acausal principle as a basis for the apparently random concurrence of phenomena.
He was suspicious of the Soviet Union's motives in supporting African liberation movements, relating that "Russia is as imperialistic as America", although he acknowledged that "in the eyes of the Third World they have a cleaner slate". He also acknowledged that the material assistance provided by the Soviets was "more valuable" to the anti-apartheid cause than the "speeches and wrist-slapping" provided by Western governments. He was cautious of the possibility of a post-apartheid South Africa getting caught up in the imperialist Cold War rivalries of the United States and the Soviet Union.
Sources: en.wikipedia.org
== Menu == Jimmy John's has three bread options: French, thick-sliced wheat, and the six-inch "Lil' John" (smaller version of French bread), as well as a lettuce-wrap option known as the Unwich, and a tortilla-wrap option. Jimmy John's has 17 different numbered sandwiches plus a B.L.T., called the J.J.B.L.T, and the Gargantuan, which includes all the meats except bacon and tuna. The 17 sandwiches may have ham, roast beef, tuna, turkey, salami, capicola, bacon, provolone cheese or parmesan cheese, or combine two or more meats and cheese. Jimmy John's has four flavors of chips, including regular, BBQ, jalapeño, and salt and vinegar. The menu also includes kosher dill pickles as well as brownies and "triple chunk" chocolate and oatmeal raisin cookies. In 2021, Jimmy John's began introducing limited-time offers to its menu. The company introduces two to three limited-time offers a year, starting with the "Smokin’ Kickin' Chicken" sandwich in February 2021. Their summer wraps, which started as a limited time offer, became a permanent installation in 2023. In March 2025, Jimmy John's introduced a new line of toasted sandwiches.
Pharmacokinetic data of oral trifluridine have only been evaluated in combination with tipiracil, which significantly affects biotransformation of the former. At least 57% of trifluridine are absorbed from the gut, and highest blood plasma concentrations are reached after two hours in cancer patients. The substance has no tendency to accumulate in the body. Plasma protein binding is over 96%. Trifluridine is metabolised by the enzyme thymidine phosphorylase to 5-trifluoromethyl-2,4(1H,3H)-pyrimidinedione (FTY), and also by glucuronidation. Elimination half-life is 1.4 hours on the first day and increases to 2.1 hours on the twelfth day. It is mainly excreted via the kidneys. Tipiracil causes Cmax (highest blood plasma concentrations) of trifluridine to increase 22-fold, and its area under the curve 37-fold, by inhibiting thymidine phosphorylase.
===== Conjugates ===== In addition to LNPs, RNAi therapeutics have targeted delivery through siRNA conjugates (e.g., GalNAc, carbohydrates, peptides, aptamers, antibodies). Therapeutics using siRNA conjugates have been developed for rare or genetic diseases such as acute hepatic porphyria (AHP), hemophilia, primary hyperoxaluria (PH) and hereditary ATTR amyloidosis as well as other cardiometabolic diseases such as hypertension and non-alcoholic steatohepatitis (NASH).
Flora (フローラ, Furōra): An android designed to resemble a teenage girl who an Alienizer named Metiussl originally named Meria (メリア) and created to serve as the brain of his robotic monster, Gigas. After meeting and befriending Sen-chan, however, she learned to develop a "heart" and be more than a machine. After being captured by Metiussl and rescued by Deka Master, Flora joins S.P.D., who accept her as a human. Flora is portrayed by Takaou Ayatsuki (彩月 貴央, Ayatsuki Takaō). Zoinaian Baytonin (ゾイナー星人ベートニン, Zoinā Seijin Bētonin): An alien from Planet Zoina who ages more slowly than humans, crashed-landed in Kyoto during Feudal Japan, and became a samurai under Ban's ancestor's tutelage. After ending up in the present, Agent Abrella manipulates the confused Baytonin into believing the Dekarangers are malicious invaders until Ban uses Kruger's D-Sword Vega to defeat Baytonin in battle. Upon realizing the truth, Baytonin leaves peacefully. Baytonin is voiced by Mantarō Iwao (岩尾 万太郎, Iwao Mantarō). Bannoshin Akaza (赤座 伴之進, Akaza Ban'noshin): Ban's ancestor from Feudal Japan who nursed the stranded Baytonin back to health and trained him in the ways of bushido and samurai conduct. Bannoshin Akaza is portrayed by Ryuji Sainei, who also portrays Ban Akaza. Barisien Attika Alpachi (バリス星人アッティカ・アルパチ, Barisu Seijin Attika Arupachi): An alien from Planet Barisie. An Alienizer named Goldom kidnaps his son and forces him to take a city block hostage, and threaten to destroy it with a bomb, so Goldom can rob a nearby bank in the confusion.
Sources: en.wikipedia.org
=== Constrained risk-taking === Psychologist Paul Rozin suggests that eating ordinary chilies is an example of a "constrained risk" like riding a roller coaster, in which extreme sensations like pain and fear can be enjoyed because individuals know that these sensations are not actually harmful. This method lets people experience extreme feelings without any significant risk of bodily harm.
=== Other Conditions === In individuals with primary hyperthyroidism, treatment via thyroid hormone therapy can reverse the hypertrophy and hyperplasia of the thyrotrophs. Individuals with a rare form of dwarfism characterized by hypothyroidism lack thyrotropic cells altogether, as this syndrome results from a mutation in the Pit-1 gene. Excess iodine present in individuals with Graves’ Disease can induce thyrotoxicosis, which is the overexpression of thyroid hormone. Sudden overexpression of the thyroid hormone is referred to as thyroid storm. Thyroid storm results in substantial decreases in the amount of thyrotropic cells in the pituitary gland. This decrease, if significant enough, can be fatal. However, with treatment, this decrease in the number of thyrotrophs can be reversed.
=== Judiciary === The judicial system was a typical hierarchical structure consisting of lower courts, a High Court and a Court of Appeal. Successive chief justices were Sir Stafford Foster-Sutton (1950–1951) (afterwards Chief Justice of Nigeria, 1955), Sir Charles Mathew (1951–1956) and Sir James Beveridge Thomson (1957–1963).
=== Religious beliefs === De Duve was brought up as a Roman Catholic. In his later years he tended towards agnosticism, if not strict atheism. However, de Duve believed that "Most biologists, today, tend to see life and mind as cosmic imperatives, written into the very fabric of the universe, rather than as extraordinarily improbable products of chance." "It would be an exaggeration to say I'm not afraid of death", he explicitly said to a Belgian newspaper Le Soir just a month before his death, "but I'm not afraid of what comes after, because I'm not a believer." He strongly supported biological evolution as a fact, and dismissive of creation science and intelligent design, as explicitly stated in one of his last books, Genetics of Original Sin: The Impact of Natural Selection on the Future of Humanity (French original 2009). He was among the seventy-eight Nobel laureates in science to endorse the effort to repeal the Louisiana Science Education Act of 2008.
=== Works cited === Army Techniques Publication 7-100.3: Chinese Tactics (PDF). Washington, D.C.: Headquarters, United States Army. 2021. ISBN 9798457607118. Goldstein, Melvyn C. (1997). The Snow Lion and the Dragon: China, Tibet, and the Dalai Lama. University of California Press. ISBN 978-0-520-21254-1. International Institute for Strategic Studies (12 February 2025). The Military Balance 2025. London: Routledge. doi:10.4324/9781003630760. ISBN 978-1-003-63076-0. Kaufman, Alison A.; Mackenzie, Peter W. (2009). The Culture of the Chinese People's Liberation Army (Report). Marine Corps Intelligence Activity. Archived from the original on 23 June 2024. Retrieved 23 June 2024. Pollpeter, Kevin; Allen, Kenneth W., eds. (14 June 2012). The PLA as Organization v2.0 (Report). China Aerospace Studies Institute. Saunders, Phillip C.; Ding, Arthur S.; Scobell, Andrew; Yang, Andrew N.D.; Joel, Wuthnow, eds. (2019). Chairman Xi Remakes the PLA: Assessing Chinese Military Reforms. Washington, D.C.: National Defense University Press. ISBN 978-1070233420. International Institute for Strategic Studies (2025). The Military Balance 2025. London: Routledge. ISBN 978-1-041-04967-8.
Sources: en.wikipedia.org
It is a synthetic peptide based on a short sequence near the start of thymosin beta-4. It is supplied as a research chemical rather than as a licensed pharmaceutical product.
No. Thymosin beta-4 is the full-length protein of about forty-three amino acids, while the fragment covers only its beginning. The two are related but are not interchangeable in experimental or analytical terms.
The label is a catalogue designation that became common in non-technical discussion. Scientific papers usually refer to the fragment by sequence or as a thymosin beta-4 N-terminal peptide.
No. Thymosin beta-4 is a 43-residue protein, while TB-500 matches only residues 17 to 23 of that chain. The two are related but differ in size, and a method that identifies one does not automatically identify the other.